Fostering the development of AI-enhanced technologies to support healthy aging at home for older adults and individuals with Alzheimer’s disease.
Using AI to Repurpose Small Molecules to Target Amyloid-tau Interactions in AD
Investigators:
Jeremy Linsley, Operant BioPharma
Neuroimmune Foundation Models for Uncovering Biomarkers in Alzheimer’s Disease and Related Dementias
Investigators:
Mariano I. Gabitto, Allen Institute
AI-assisted Prediction of Healthy Aging and Alzheimer’s Disease Progression
Investigators:
Chaitanya Gupta, ProbiusDX Inc.
Steven Arnold, Massachusetts General Hospital
